Sponsor pipeline

Alliance Foundation Trials, LLC. clinical trial pipeline

Get alerts when Alliance Foundation Trials, LLC.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

5 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 3 with minor changes only.

  1. Notable

    CHIO3 Trial · CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

    Results posted: Sep 23, 2026

    Also in this update: Primary completion date changed from estimate of Jul 2026 to Feb 24, 2025; Study completion pushed from Jul 2026 to Jul 2027

    Alliance Foundation Trials, LLC.Phase 2 NCT04062708 Registry history of NCT04062708 on ClinicalTrials.gov (opens the registry)

Show 3 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1
Phase 2
5
Phase 3
2
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when Alliance Foundation Trials, LLC.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free